Sentences with phrase «than no program at»

In other words, even a weak program may be better than no program at all, as can be seen in the results for whites.

«Even a weak program may be better than no program at all, as can be seen in the results for whites,» Cascio writes.

Poor or partial implementation of a community school was no better than no program at all.

This work amounts to more than a program at conferences or webinar for CUBE.

Not exact matches

Before joining the Times, Kate worked for more than six years as an on - air television reporter at CNBC, appearing on the channel's daytime programming with news, interviews, and analysis.

At this stage, the advice you get from them will be worth more than any business school program.»

The personal loan was easier to get than one might expect: Sullivan applied for it before finishing his MBA program at Norwich University, meaning his student loans were still accumulating.

It will be at least three years, he predicts, before buyers (other than Netflix and HBO) will start actively owning programs.

He was interested in doing more than just owning buildings; he graduated from Carleton University's School of Architecture in 1997, at the age of 75, and later donated $ 5.5 million to the program.

«The degree of difficulty of getting the rare earths programmed and moving may be more than they can manage at the moment, in a practical way,» says Babson.

If you can't offer salaries that are at or exceed your competition, then there may be other options such as providing better employee benefits and work - life balance programs than competitors.

The Perth - based junior announced this week that final assay results from a 45 - hole aircore / RC drill program at the Obelisk prospect within the Paterson mining region in the north of W.A, had extended the size of the system from 1 km to more than 4 km and it remains open in all directions.

In 2017, Walmart has also introduced a membership - free, two - day shipping program, a discount for customers who pick up an online order at a order rather than have it shopped, curbside grocery pickup at hundreds of stores and other novel services such as having a Walmart store worker drop off an online order on the way home after their shift.

In her time at Cinnabon, Cole has advanced the company's licensing programs with other franchises, including Cinnabon Delights at Taco Bell, Minibons at more than 700 Burger Kings and International Delight creamer that tastes like the company's famous cinnamon buns.

«We're not saying no one should ever drink at all — we're just saying if you do drink, even trying to keep it down to less than one drink a day would be a smart choice,» Alice Bender, a registered dietitian who is the head of nutrition programs for the AICR, told Business Insider in May.

That's why Western Union is interested in a pilot program — on a system like Bitcoin or Ripple, a transaction takes mere minutes to complete and at a much lower cost than traditional money transfers.

Programs like Dao's Twiistup conference, Koblasa's Start - Up Weekend LA and Start - Up Nights, and Suster's Launchpad L.A. certainly help make L.A. feel smaller than it is, at least for a start - up.

Clinton's apparent popularity likely stems from her developing connections in the tech sector over a longer period of time than other Oval Office contenders, according to Mark Schmitt, director of the political reform program at independent think tank New America Foundation.

Black & Denim was a winner of the MillerCoors Urban Entrepreneurship Business Plan Competition Series, Macy's gave them a week in its minority business development program called The Workshop at Macy's, and they recently raised more than $ 35,000 in their Kickstarter campaign.

The company is launching Vice Studios, a «global multi-platform scripted studio» aimed at developing original content that Vice can market around the world after the company signed content deals earlier this year to make its programming available in more than 80 territories by the end of the year.

«Rather than offering people one or two rides, the goal of this program is to give participants access to our fleet every day, at any time, to go anywhere within an area that's about twice the size of San Francisco.»

It says its stores are fulfilling more than half of its total online sales through «pickup at stores» and «ship from store» programs.

But J. Gerald Hebert, director of the Voting Rights and Redistricting Program at the public - interest Campaign Legal Center in Washington, said the states drew districts with more black voters than necessary to «dilute their voting strength in order to achieve a partisan gain.»

At Harvard, Grab, the Singapore - based taxi hailing app that has raised more than $ 680 million in venture capital backing, has its roots in the Rock Summer Fellowship program.

More than three — quarters of the student body in the MBA program at VIU are international students, and there are many opportunities to focus on international business, including exchange programs across the globe.

Infosys, which employs more than 200,000 workers worldwide, was under the spotlight last year as President Donald Trump targeted the American H - 1B visa program that tech companies have heavily relied upon to temporarily bring in workers from other countries at lower wages.

To date, the startup — co-founded with COO Igor Bratnikov, a fellow émigré Raygorodskaya met as a teenager at a Russian - language afterschool math program — has booked more than $ 1 billion in partner ticket sales and now generates over $ 100 million in annual revenue.

There is room here for activist public policy aimed at assisting people as soon as they become unemployed — including very fast interventions to have resumés updated, interview skills improved and much shorter - duration job training programs (rather than ones that last months or years).

Everyone wants to be more global, to infuse ethics and integrity into the curriculum, to teach students to be more entrepreneurial and innovative, and to put more of a challenge into MBA programs that, at some places, have become little more than a two - year search for a better job.

I've got to think that each of these people spent more than the average couple of seconds looking at a typical magazine ad to execute this program.

The Federal Communications Commission's Lifeline program paid at least $ 1.2 million to duplicate or deceased recipients and more than one - third of participants out of 3.5 million reviewed appeared not to be eligible, the Government Accountability Office said in a report released on Thursday.

The unfortunate reality is the opposite: Electric car programs (or programs for any vehicle that doesn't burn hydrocarbons) at the major manufacturers are small to non-existent, constituting an average of far less than 1 % of their total vehicle sales.

The majority of WashU's more than 6,800 undergraduates study in the arts and sciences school, while nearly 1,000 students enroll in the university's high - ranking undergraduate business program at Olin Business School.

Among the top 20 MBA programs in the U.S., at least four schools — Yale, Harvard, Northwestern, and UCLA — have increased their average scholarship payouts to students by more than 100 % since the 2004 - 2005 academic year.

Groups is very simple: For $ 65 a week, it offers group therapy in areas plagued by opioid addiction — targeting towns with fewer than 10,000 residents and little access to recovery programs — so people at different stages of recovery can learn from one another.

According to the SBA, only 29 percent of full - time employees in companies with fewer than 25 employees currently work at firms that sponsor a retirement program.

Lawmakers created the choice program in 2014 after a massive scandal involving wait time cover - ups at more than 100 VA facilities around the country.

Nearly 65 % of Prevent program participants are still engaged with the program at 12 months, significantly higher than the 6.6 % average for leading commercial weight loss programs.

The combined rewards programs are growing faster than ever, says Marriott, at around 1 million new members a month.

Because if you look at Prime members, they buy more on Amazon than non-Prime members, and one of the reasons they do that is once they pay their annual fee, they're looking around to see, «How can I get more value out of the program?»

Moreover, the program has hosted more than 40 forums and speakers for the incubator's start - up teams this summer, Gaiss says, and at one of them Casinelli met a programmer from the Massachusetts Institute of Technology who was able to talk him through a problem he was having.

Ranking at No. 855 on the Inc. 5000, this health company offers peer review programs to more than 60 workers» compensation and managed - care organizations to assist in the claims management process.

The temporary foreign worker program was first under fire in the fall of 2012, when it came to light that approval was granted to Chinese - owned HD Mining International to bring more than 200 people from China to work at its coal mine near Tumbler Ridge, B.C.

«I'm eating healthy because I like the way it makes me feel» or «It's beautiful outside — I'm going to take a walk» are better bets than lamenting your new diet or exercise program, Marc S. Jacobson, a professor of pediatrics at Nassau University Medical Center, tells Parents.com.

The company recently made analysts happy by announcing a $ 1.2 - billion stock repurchasing program, plus it's cheaper than many other alcohol companies, trading at 13 times earnings.

About 300 survivors live at the HIA or attend its day programs, among them Feinstein's son, Barry, who was injured in a car crash more than 20 years ago.

Effective programs — the kind found on the National Registry — are usually created by psychologists and other social scientists who are better at research than marketing their efforts.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tPrograms (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Satwani — who hasn't delivered the CAR - T therapy but is heading up the program at Columbia, one of the 32 sites Novartis will use — said patients would need to be monitored closely for about a month, meaning they'd need to be less than a two - hour drive from their hospital.

«So effective training programs represent a far greater return on investment than what you would at first think.